Advicenne Overview

  • Founded
  • 2007
Founded
  • Status
  • Public
  • Employees
  • 29
Employees
  • Stock Symbol
  • ADVIC
Stock Symbol
  • Share Price
  • $8.35
  • (As of Tuesday Closing)

Advicenne General Information

Description

Advicenne SA is a late-stage biopharmaceutical company. The company is engaged in the development of paediatric friendly therapeutics for the treatment of orphan renal diseases and niche neurology indications. Its goal is to improve the lives of patients from early childhood through adulthood.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Stock Exchange
PAR
Primary Office
  • 22 Rue de la Paix
  • 75002 Paris
  • France
+33 01 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Advicenne Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.35 $8.03 $6.27 - $19.71 $79.2M 9.9M 38.8K -$1.94

Advicenne Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 51,720 59,312 44,800 117,557
Revenue 2,586 2,238 1,404 909
EBITDA (16,496) (15,733) (6,281) (5,933)
Net Income (16,151) (15,353) (5,458) (5,251)
Total Assets 27,996 25,674 37,948 46,329
Total Debt 10,212 503 480 841
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Advicenne Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Advicenne‘s full profile, request access.

Request a free trial

Advicenne Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Advicenne SA is a late-stage biopharmaceutical company. The company is engaged in the development of paediatric friendly
Drug Delivery
Paris, France
29 As of 2019
000.00
0000 0000-00-00
00000000 000.00

0000 000

por incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
0000000000000
Cambridge, MA
000 As of 0000
00.000
000000000 00.000

00000 00

t esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
0000000000000
Burnaby, Canada
000 As of 0000
0000
00000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Advicenne Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SAGE Therapeutics Formerly VC-backed Cambridge, MA 000 00.000 000000000 00.000
00000 000000000000 Formerly VC-backed Burnaby, Canada 000 0000 00000000 0000
000000000 Venture Capital-Backed New York, NY 00 00000 00000000000 00000
You’re viewing 3 of 3 competitors. Get the full list »

Advicenne Executive Team (12)

Name Title Board Seat Contact Info
Nathalie Lemarié-Barbier Director of Regulatory Affairs & Qualified Person
Florie Guillaumin CMC Regulatory Affairs Officer
Laurene Archambeaud Clinical Development Project Manager
Didier Laurens Chief Executive Officer & Board Member
Caroline Roussel-Maupetit Co-Founder & Director of Operations
You’re viewing 5 of 12 executive team members. Get the full list »

Advicenne Board Members (7)

Name Representing Role Since
Andre Ulmann Ph.D Self Board Member 000 0000
Didier Laurens Advicenne Chief Executive Officer & Board Member 000 0000
Françoise Brunner-Ferber Ph.D Self Board Member 000 0000
Jean-Pierre Lefoulon Self Board Member 000 0000
Philippe Boucheron Bpifrance Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Advicenne Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial